<div><div></div><div><span><ul><li><span>According to estimates from 11 analysts, Progyny, Inc. stock's average price target has risen from $29.55 to $29.73, with forecasts ranging from $26 to $31 per share</span></li><li><span>Based on the Jun. 1 closing price, the updated target implies approximately 13% potential upside</span></li><li><span>Consensus rating remains at “Buy” across 11 covering analysts, with 10 Buys, 1 Holds and 0 Sells</span></li></ul><p><span>Explore more price target data and ratings for Progyny, Inc. on the </span><span>, and track all previous and future analyst recommendations for Progyny, Inc. in the dedicated </span>News Flow<span>.</span></p><section><b><span class="heading-JaE7wgR2">Disclaimer</span></b><div><span>Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.</span></div></section></span></div></div>

PGNY

<p>Analysts have raised Progyny, Inc.'s 12-month average price target from $29.55 to $29.73, implying a 13% upside based on the June 1 closing price. The consensus rating remains 'Buy' among 11 covering analysts, with 10 buys and 1 hold. Price forecasts range from $26 to $31 per share.</p>

Progyny, Inc. Stock 12‑Month Price Target Raised to $29.73, Implies 13% Upside